Geographic variation and disparity in stimulant treatment of adults and children in the united states in 2008

Psychiatric Services

Volumn 64, Issue 11, 2013, Pages 1079-1086

  McDonald, Douglas C ^a   Jalbert, Sarah Kuck ^a  

^a ABT ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; LISDEXAMFETAMINE; METHYLPHENIDATE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; DRUG SURVEILLANCE PROGRAM; EDUCATIONAL STATUS; ETHNICITY; FAMILY MEDICINE; FEMALE; FUNDING; GEOGRAPHY; HEALTH DISPARITY; HEALTH INSURANCE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNINSURED; PEDIATRICIAN; PHARMACY; PHYSICIAN; POVERTY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; RACE; SOCIAL STATUS; SPECIAL EDUCATION; UNITED STATES; URBAN AREA;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HUMANS; MALE; MEDICALLY UNINSURED; PRESCRIPTIONS; PREVALENCE; SPATIAL ANALYSIS; UNITED STATES;

EID: 84887907412     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.004442012     Document Type: Article

References (38)

1. Olfson M, Gameroff MJ, Marcus SC, et al: National trends in the treatment of attention deficit hyperactivity disorder. American Journal of Psychiatry 160:1071-1077, 2003
2. Zuvekas SH, Vitiello B: Stimulant medication use among children: a 12-year perspective. American Journal of Psychiatry 169:160-166, 2011
3. Froehlich TE, Lanphear BP, Epstein JN, et al: Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Archives of Pediatrics and Adolescent Medicine 161:857-864, 2007
4. Scahill L, Schwab-Stone M: Epidemiology of ADHD in school-age children. Child and Adolescent Psychiatric Clinics of North America 9:541-555, 2000
5. Kessler RC, Adler L, Barkley R, et al: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry 163:716-723, 2006
6. Fayyad J, De Graaf R, Kessler R, et al: Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. British Journal of Psychiatry 190: 402-409, 2007
7. Faraone SV, Sergeant J, Gillberg C, et al: The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104-113, 2003
8. Wilens TE, Faraone SV, Biederman J: Attention-deficit/hyperactivity disorder in adults. JAMA 292:619-623, 2004
9. Visser SN, Lesesne CA: Mental health in the United States: prevalence of diagnosis and medication treatment for attentiondeficit/hyperactivity disorder-United States, 2003. Morbidity and Mortality Weekly Report 54:842-847, 2005
10. Radigan M, Lannon P, Roohan P, et al: Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population. Journal of Child and Adolescent Psychopharmacology 15:44-56, 2005
11. Baumgardner DJ, Schreiber AL, Havlena JA, et al: Geographic analysis of diagnosis of attention-deficit/hyperactivity disorder in children: eastern Wisconsin, USA. International Journal of Psychiatry in Medicine 40:363-382, 2010
12. Wennberg JE, Wennberg DE: The Dartmouth Atlas of Health Care in Michigan: Blue Cross Blue Shield Blue Care of Michigan, 2000. Available at www.bcbsm.org/atlas/foreword.shtml
13. Cox ER, Motheral BR, Henderson RR, et al: Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics 111:237-243, 2003
14. Castle L, Aubert RE, Verbrugge RR, et al: Trends in medication treatment for ADHD. Journal of Attention Disorders 10:335-342, 2007
15. Fulton BD, Scheffler RM, Hinshaw SP, et al: National variation of ADHD diagnostic prevalence and medication use: health care providers and education policies. Psychiatric Services 60:1075-1083, 2009
16. Hoagwood K, Jensen PS, Feil M, et al: Medication management of stimulants in pediatric practice settings: a national perspective. Journal of Developmental and Behavioral Pediatrics 21:322-331, 2000
17. Bruckner TA, Hodgson A, Mahoney CB, et al: Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications. Pharmacoepidemiology and Drug Safety 21: 442-449, 2012
18. Bokhari F, Mayes R, Scheffler RM: An analysis of the significant variation in psychostimulant use across the US. Pharmacoepidemiology and Drug Safety 14: 267-275, 2005
19. Mannuzza SK, Klein RG: Long-term prognosis in attention-deficit/ hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America 9:711-726, 2000
20. Charach A, Ickowicz A, Schachar R: Stimulant treatment over five years: adherence, effectiveness, and adverse effects. Journal of the American Academy of Child and Adolescent Psychiatry 43:559-567, 2004
21. Automation of Reports and Consolidated Orders System (ARCOS), Retail Drug Summary. Washington, DC, US Department of Justice, Drug Enforcement Administration. Accessed Dec 11, 2011. Available at www.deadiversion.usdoj.gov/ arcos
22. Gardner W, Kelleher KJ, Wasserman R, et al: Primary care treatment of pediatric psychosocial problems: a study from pediatric research in office settings and ambulatory sentinel practice network. Pediatrics 106:E44, 2000
23. American Community Survey. Washington, DC, US Census Bureau. Available at www-958.ibm.com/software/data/cognos/manyeyes/ datasets/gini-coefficient-by- county-2000-20/versions/1. Accessed May 24, 2012
24. County Level Food Stamp/SNAP Recipient File. Rockville, Md, US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Professions, Area Resource File Access System, 2008. Available at arf.hrsa.gov/download.htm
25. Small Area Income Poverty Estimates. Rockville, Md, US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Professions, Area Resource File Access System, 2008.Available at arf.hrsa. gov/download.htm
26. CDC health disparities and inequalities report-United States, 2011. Morbidity and Mortality Weekly Report 60(suppl), Jan 14, 2011. Available at www.cdc.gov/mmwr/pdf/other/su6001.pdf
27. Small Area Health Insurance Estimates. Rockville, Md, US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Professions, Area Resource File Access System, 2008. Available at arf.hrsa.gov/download.htm
28. Public Education-Secondary Education Finance Data. Washington, DC, US Census Bureau. Available at www.census.gov/govs/school/. Accessed July 18, 2012
29. Zhang Y, Baicker K, Newhouse JP: Geographic variation in the quality of prescribing. New England Journal of Medicine 363:1985-1988, 2010
30. Geographic Variation in Health Care Spending. Washington, DC,Congressional Budget Office, 2008
31. McDonald D, Carlson K, Izrael D: Geographic variation in opioid prescribing in the US. Journal of Pain 13:988-996, 2012
32. Wennberg JE: Time to tackle unwarranted variations in practice. BMJ 342:1513, 2011
33. Levy F, Hay DA, McStephen M, et al: Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. Journal of the American Academy of Child and Adolescent Psychiatry 36:737-744, 1997
34. Biederman J, Faraone SV, Keenan K, et al: Family-genetic and psychosocial risk factors in DSM-3 attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry 29:526-533, 1990
35. Angold A, Erkanli A, Egger HL, et al: Stimulant treatment for children: a community perspective. Journal of the American Academy of Child and Adolescent Psychiatry 39:975-984, discussion 984-994, 2000
36. Chassin MR: Explaining geographic variations: the enthusiasm hypothesis. Medical Care 31(suppl):YS37-YS44, 1993
37. Hashimoto H, Noguchi H, Heidenreich P, et al: The diffusion of medical technology, local conditions, and technology re-invention: a comparative case study on coronary stenting. Health Policy 79:221-230, 2006
38. Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management, Wolraich M, et al: ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/ hyperactivity disorder in children and adolescents. Pediatrics 128:1007-1022, 2011